6 biology,” Rejuvenation Research, vol. 7, no. 2, pp. 134–145, 2004. [3] N. Verzijl, J. DeGroot, Z. C. Ben et al., “Crosslinking by advanced glycation end products increases the stiﬀness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthri- tis,” Arthritis & Rheumatism, vol. 46, no. 1, pp. 114–123, 2002. [4] J. A. Martin, S. M. Ellerbroek, and J. A. Buckwalter, “Age- related decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins,” Journal of Orthopaedic Research, vol. 15, no. 4, pp. 491–498, 1997. [5] E. A. Zimmermann, E. Schaible, H. Bale et al., “Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 35, pp. 14416–14421, 2011. [6] J. Sellam and F. Berenbaum, “The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis,” Nature Reviews Rheumatology, vol. 6, no. 11, pp. 625–635, 2010. [7] M. J. Benito, D. J. Veale, O. FitzGerald, W. B. van den Berg, and B. Bresnihan, “Synovial tissue inﬂammation in early and late osteoarthritis,” Annals of the Rheumatic Diseases, vol. 64, no. 9, pp. 1263–1267, 2005. [8] C. Jin, P. Frayssinet, R. Pelker et al., “NLRP3 inﬂammasome plays a critical role in the pathogenesis of hydroxyapatite- associated arthropathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 36, pp. 14867–14872, 2011. [9] V. Valderrabano, V. von Tscharner, B. M. Nigg et al., “Lower leg muscle atrophy in ankle osteoarthritis,” Journal of Orthopaedic Research, vol. 24, no. 12, pp. 2159–2169, 2006. [10] A. Mundermann, C. O. Dyrby, and T. P. Andriacchi, “Sec- ondary gait changes in patients with medial compartment knee osteoarthritis: increased load at the ankle, knee, and hip during walking,” Arthritis & Rheumatism, vol. 52, no. 9, pp. 2835–2844, 2005. [11] T. Miyazaki, M. Wada, H. Kawahara, M. Sato, H. Baba, and S. Shimada, “Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis,” Annals of the Rheumatic Diseases, vol. 61, no. 7, pp. 617–622, 2002. [12] N. Foroughi, R. Smith, and B. Vanwanseele, “The association of external knee adduction moment with biomechanical vari- ables in osteoarthritis: a systematic review,” Knee, vol. 16, no. 5, pp. 303–309, 2009. [13] B. G. Pietrosimone, J. Hertel, C. D. Ingersoll, J. M. Hart, and S. A. Saliba, “Voluntary quadriceps activation deﬁcits in patients with tibiofemoral osteoarthritis: a meta-analysis,” PM & R, vol. 3, no. 2, pp. 153–162, 2011. [14] E. M. Roos, W. Herzog, J. A. Block, and K. L. Bennell, “Muscle weakness, aﬀerent sensory dysfunction and exercise in knee osteoarthritis,” Nature Reviews Rheumatology, vol. 7, no. 1, pp. 57–63, 2011. [15] N. A. Segal, J. C. Torner, D. Felson et al., “Eﬀect of thigh strength on incident radiographic and symptomatic knee osteoarthritis in a longitudinal cohort,” Arthritis Care and Research, vol. 61, no. 9, pp. 1210–1217, 2009. [16] M. V. Hurley, “The role of muscle weakness in the patho- genesis of osteoarthritis,” Rheumatic Disease Clinics of North America, vol. 25, no. 2, pp. 283–298, 1999. [17] R. W. Bohannon and A. A. Williams, “Normal walking speed: a descriptive meta-analysis,” Physiotherapy, vol. 97, no. 3, pp. 182–189, 2011. Journal of Aging Research [18] J. O. Judge, R. B. Davis III, and S. Ounpuu, “Step length reduc- tions in advanced age: the role of ankle and hip kinetics,” Jour- nals of Gerontology A, vol. 51, no. 6, pp. M303–M312, 1996. [19] H. B. Menz, S. R. Lord, and R. C. Fitzpatrick, “Age-related diﬀerences in walking stability,” Age and Ageing, vol. 32, no. 2, pp. 137–142, 2003. [20] K. S. Rudolph, L. C. Schmitt, and M. D. Lewek, “Age-related changes in strength, joint laxity, and walking patterns: are they related to knee osteoarthritis?” Physical Therapy, vol. 87, no. 11, pp. 1422–1432, 2007. [21] Y. C. Pai, W. Z. Rymer, R. W. Chang, and L. Sharma, “Eﬀect of age and osteoarthritis on knee proprioception,” Arthritis & Rheumatism, vol. 40, no. 12, pp. 2260–2265, 1997. [22] J. Runhaar, B. W. Koes, S. Clockaerts, and S. M. Bierma- Zeinstra, “A systematic review on changed biomechanics of lower extremities in obese individuals: a possible role in development of osteoarthritis,” Obesity Reviews, vol. 12, no. 12, pp. 1071–1082, 2011. [23] D. T. Felson, J. J. Anderson, A. Naimark, A. M. Walker, and R. F. Meenan, “Obesity and knee osteoarthritis. The Framingham study,” Annals of Internal Medicine, vol. 109, no. 1, pp. 18–24, 1988. [24] A. Anandacoomarasamy, S. Leibman, G. Smith et al., “Weight loss in obese people has structure-modifying eﬀects on medial but not on lateral knee articular cartilage,” Annals of the Rheumatic Diseases, vol. 71, no. 1, pp. 26–32, 2012. [25] D. L. Waters and R. N. Baumgartner, “Sarcopenia and obesity,” Clinics in Geriatric Medicine, vol. 27, no. 3, pp. 401–421, 2011. [26] J. Campisi and F. D’Adda di Fagagna, “Cellular senescence: when bad things happen to good cells,” Nature Reviews Mole- cular Cell Biology, vol. 8, no. 9, pp. 729–740, 2007. [27] B. Dozin, M. Malpeli, L. Camardella, R. Cancedda, and A. Pietrangelo, “Response of young, aged and osteoarthritic human articular chondrocytes to inﬂammatory cytokines: molecular and cellular aspects,” Matrix Biology, vol. 21, no. 5, pp. 449–459, 2002. [28] T. Aigner, M. Hemmel, D. Neureiter et al., “Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of pro- liferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage,” Arthritis & Rheumatism, vol. 44, no. 6, pp. 1304– 1312, 2001. [29] E. Regan, J. Flannelly, R. Bowler et al., “Extracellular superox- ide dismutase and oxidant damage in osteoarthritis,” Arthritis & Rheumatism, vol. 52, no. 11, pp. 3479–3491, 2005. [30] E. N. B. Davidson, D. F. Remst, E. L. Vitters et al., “Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice,” Journal of Immunology, vol. 182, no. 12, pp. 7937–7945, 2009. [31] J. D. Cravero, C. S. Carlson, H. J. Im, R. R. Yammani, D. Long, and R. F. Loeser, “Increased expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth factor 1-mediated cell survival and proteoglycan synthesis,” Arthritis & Rheumatism, vol. 60, no. 2, pp. 492–500, 2009. [32] M. M. Temple, W. C. Bae, M. Q. Chen et al., “Age- and site-associated biomechanical weakening of human articular cartilage of the femoral condyle,” Osteoarthritis and Cartilage, vol. 15, no. 9, pp. 1042–1052, 2007. [33] S. S. Nah, I. Y. Choi, B. Yoo, Y. G. Kim, H. B. Moon, and C. K. Lee, “Advanced glycation end products increases mat- rix metalloproteinase-1, -3, and -13, and TNF-α in human